| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.
BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 919.9K | - | - | |
| CEO | 497.0K | $34.30M | - | |
| CFO | 336.5K | $26.88M | - | |
| Other | 122.7K | $9.80M | - | |
| Dir | 120.8K | $10.15M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Kumar Neil | CEO And President | Sell | 120,000 | $7.67 | $920,856.00 | -7.4% | +102.2% | +390.8% | |
| Dec 21, 2022 | Kumar Neil | CEO And President | Sell | 200,000 | $0.00 | - | -16.7% | +63.0% | +369.6% | |
| Nov 17, 2022 | Stephenson Brian C | Secretary, Treasurer &CFO | Sale+OE | 19,678 | $9.40 | $184,985.01 | -5.5% | +26.4% | +203.1% | |
| Nov 17, 2022 | Kumar Neil | CEO And President | Sale+OE | 34,640 | $9.40 | $325,605.61 | -0.7% | +26.4% | +203.1% | |
| Mar 15, 2022 | Ellis Andrea | Director | Buy | 12,000 | $8.39 | $100,680.00 | New | -30.1% | +67.5% | |
| Mar 14, 2022 | Dachille Douglas A. | Director | Buy | 10,000 | $8.19 | $81,934.00 | +100.0% | -27.9% | +76.6% | |
| Jan 5, 2022 | Dachille Douglas A. | Director | Buy | 10,000 | $16.37 | $163,650.00 | New | -19.0% | -48.6% | |
| Dec 30, 2021 | Lo Andrew | Director | Buy | 7,500 | $13.18 | $98,850.00 | +18.5% | -28.7% | -47.6% | |
| Dec 30, 2021 | Daniels Ronald J | Director | Buy | 22,147 | $13.49 | $298,678.53 | -188.6% | -28.7% | -47.6% | |
| Dec 29, 2021 | Hassan Fred | Director | Buy | 19,300 | $14.17 | $273,390.29 | New | -23.5% | -46.7% |